The effects of sulforaphane on the liver and remote organ damage in hepatic ischemia-reperfusion model formed with pringle maneuver in rats.
BACKGROUND
The purpose of this study was to investigate the effect of Sulforaphane on ischemia/ reperfusion (IR) injury of the liver and distant organs resulting from liver blood flow arrest.


METHODS
Fourty Wistar rats were assigned into four groups, each included 10 rats were used. Group I as only laparatomy, Group II laparatomy and Sulforaphane application, Group III hepatic IR; and Group IV as hepatic IR and Sulforaphane application group. Animals were subjected to liver ischemia for 30 min and then reperfusion is started. 5 mg/kg Sulforaphane was applied via oral lavage 15 minutes before initiating the experimental study. Blood samples were taken from the animals for biochemical analysis at 60th minutes of the experiment in the first and second groups; 30 minutes after beginning reperfusion in the third and forth groups. Simultaneously, liver, lung and kidney tissues were sampled for biochemical and histopathological examinations.


RESULTS
The administration of sulforaphane significantly reduced the serum TOA and liver TOA levels, increased the serum TAC and liver TAC levels and also decreased The OSI and liver OSI levels. In the histopathologic examination, the injury was reduced by the administration of sulforaphane. Administration of sulforaphane did not lead to any significant changes in any parameter including histopathological parameters in both the kidney and the lung.


CONCLUSIONS
Sulforaphane reduced the liver oxidative stress from I/R injury. A histological injury in liver was reduced by sulforaphane administration. However, there were no significant effects of sulforaphane on the remote organ injuries induced by IR.
Department of General Surgery, Dicle University Medical Faculty, Diyarbakir, Turkey. Electronic address: dragtiz@hotmail.com.
Abdullah
A
Oguz
Department of General Surgery, Dicle University Medical Faculty, Diyarbakir, Turkey.
Murat
M
Kapan
Department of Biochemistry, Dicle University Medical Faculty, Diyarbakir, Turkey.
Ibrahim
I
Kaplan
Department of Pathology, Dicle University Medical Faculty, Diyarbakir, Turkey.
Ulas
U
Alabalik
Department of General Surgery, Dicle University Medical Faculty, Diyarbakir, Turkey.
Burak Veli
BV
Ulger
Department of General Surgery, Dicle University Medical Faculty, Diyarbakir, Turkey.
Omer
O
Uslukaya
Department of General Surgery, Dicle University Medical Faculty, Diyarbakir, Turkey.
Ahmet
A
Turkoglu
Department of General Surgery, Medical Park Hospital, Elazig, Turkey.
Yilmaz
Y
Polat
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D004195:Disease Models, Animal; D004334:Drug Administration Schedule; D007511:Ischemia / Q000150:complications; D017879:Isothiocyanates / Q000494:pharmacology*; D007668:Kidney / Q000098:blood supply*; D008099:Liver / Q000098:blood supply*; D008107:Liver Diseases / Q000188:drug therapy; D008168:Lung / Q000098:blood supply*; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000473:pathology; D013454:Sulfoxides
D016588:Anticarcinogenic Agents; D017879:Isothiocyanates; D013454:Sulfoxides; C016766:sulforaphane
Hepatic ischemia-reperfusion; Kidney; Liver; Lung; Remote organs; Sulforaphane